Manhattan Research Releases Report on the Future of Physician Customer Service Portals

Manhattan ResearchOver the past year, physician visitation to customer service portals decreased while interest in using them actually increased. To help biopharma companies bridge the gap between the current portal landscape and unmet physician demand, pharmaceutical and healthcare market research company Manhattan Research just released its latest physician module report, "The Case for Customer Care: Service Portals and a Successfully Integrated CRM System" as part of its ePharma Physicianâ v8.0 market research and strategic advisory service. The report discusses future implications for physician customer service portals and reveals market data and best practices for biopharma companies looking to reach target audiences through this channel.

"Physicians rely on a diverse channel mix to gather biopharma and healthcare information and fewer of them are willing to take face-to-face sales rep meetings - challenging companies to re-invent the traditional service model," said the author of the report, Meredith Abreu Ressi, VP of research for Manhattan Research. "Many have begun building full-service portals for physicians where they can access journal reprints, order samples, download patient education information, and even videoconference online with a rep."

"Physicians are not saying that they want to do away with the sales force entirely," continues Ressi. "Most physicians still want to be able to talk to a rep when they have a question, or when there's a new product launch - but if it's a routine question or transaction, they'd prefer to conduct those activities online, when it's convenient for them. This is really about providing physicians with a variety of channels to access information so they can choose the method that is most convenient and useful to them."

Report Outline
I. Physician Portals: Where Are We Now?

  • Trending and Current Adoption
  • Top Portals
  • Physician Demand for Portals (by company)
  • Who Uses Portals Today?

II. Developing a Physician Portal: Features and Physician Expectations

  • What Are They Using? What do They Want to Use?
  • Differences by Specialty
  • Features to Consider
    • Email Customer Service
    • Live Video Rep or Call Center
    • Integrating Medical Affairs

III. If You Build It, They Won’t Just Come: Marketing Your Portal

  • Marketing the Portal Online
  • Top Portals
  • Selling the Site: Public vs. Password-Protected Content
  • Sales Force Buy-in
  • Closed Loop CRM

More information about the report’s contents can be found here:
http://www.manhattanresearch.com/products/Research_Modules/
Physician/physician-customer-service-portals.aspx

About ePharma Physician® v8.0
ePharma Physician® v8.0 was conducted via online survey methodology in Q2 2008 among 1,681 online practicing U.S. physicians. The study and advisory service product has determined the leading online physician destinations based on the number of physician visitors as well as the content satisfaction of those who visit and provides in-depth analysis of top product and corporate pharmaceutical websites, health portals, online journal sites, specialty-specific sites, newsletters, society sites, physicians and Web 2.0, physician online communities, electronic detailing, Tablet PCs, online conferences, physician customer service portals, tech-enabled sales forces, physician CRM, and more. For more information, visit: http://www.manhattanresearch.com/products/Strategic_Advisory/ePP/

About Manhattan Research
Manhattan Research, a Decision Resources, Inc. company, is a leading market research and advisory firm for pharmaceutical and healthcare companies. For more information, visit http://www.manhattanresearch.com.

About Decision Resources, Inc.
Decision Resources, Inc. is a cohesive portfolio of companies that offers best-in-class, high-value information and insights on important sectors of the healthcare industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision Resources, Inc. at http://www.DecisionResourcesInc.com.

Most Popular Now

Bayer to accelerate drug discovery with Google Clo…

Bayer AG and Google Cloud announced a collaboration to drive early drug discovery that will apply Google Cloud's Tensor Processing Units (TPUs), which are custom-develope...

NextPoint Therapeutics announces $80 million Serie…

NextPoint Therapeutics, a biotechnology company developing a new world of precision immuno-oncology, announced today that it raised $80 million in Series B financing co-l...

AstraZeneca to acquire CinCor Pharma to strengthen…

AstraZeneca has entered into a definitive agreement to acquire CinCor Pharma, Inc. (CinCor), a US-based clinical-stage biopharmaceutical company, focused on developing no...

Acquisition of Neogene Therapeutics completed

AstraZeneca has completed the acquisition of Neogene Therapeutics Inc. (Neogene), a global clinical-stage biotechnology company pioneering the discovery, development and ...

Pfizer expands 'An Accord for a Healthier World' p…

Pfizer Inc. (NYSE: PFE) announced that it has significantly expanded its commitment to An Accord for a Healthier World to offer the full portfolio of medicines and vaccin...

500,000 missed out on blood pressure lowering drug…

Nearly half a million people missed out on starting medication to lower their blood pressure during the COVID-19 pandemic, according to research supported by the British ...

Study identifies potential new approach for treati…

Targeting iron metabolism in immune system cells may offer a new approach for treating systemic lupus erythematosus (SLE) - the most common form of the chronic autoimmune...

Nanotechnology may improve gene therapy for blindn…

Using nanotechnology that enabled mRNA-based COVID-19 vaccines, a new approach to gene therapy may improve how physicians treat inherited forms of blindness. A collabo...

Roche announces the European Commission approval o…

Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that the European Commission (EC) has approved Xofluza® (baloxavir marboxil) in children aged one year and above for the trea...

Modified CRISPR-based enzymes improve the prospect…

Many genetic diseases are caused by diverse mutations spread across an entire gene, and designing genome editing approaches for each patient’s mutation would be impractic...

A soybean protein blocks LDL cholesterol productio…

A protein in soybeans blocks the production of a liver enzyme involved in the metabolism of triglycerides and low-density lipoprotein, scientists found in a recent study...

Discovery of anti-cancer chemistry makes skullcap …

The evolutionary secrets that enable the medicinal herb known as barbed skullcap to produce cancer fighting compounds have been unlocked by a collaboration of UK and Chin...